Behbahani Ali

CIK 000161386723 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001613867

Recent Transactions

50 trades

Other
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-07-01−1,000,000→ 6,692,298 total
Other
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-07-01+15,000→ 15,000 total
Other
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-07-01−15,000→ 0 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Stock Option (Right to Buy)
2026-06-26+40,000→ 40,000 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2026-06-19$1.66/sh+8,961→ 102,529 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-11+25,800→ 25,800 total
Award
Korro Bio, Inc.$KRRO
Stock Option (Right to Buy)
2026-06-10+14,677→ 14,677 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2026-06-10+37,000→ 37,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-06-05+13,000→ 13,000 total
Disposition from Tender
Arcellx, Inc.$ACLX
Common Stock
2026-04-28−1,925→ 0 total
Disposition from Tender
Arcellx, Inc.$ACLX
Common Stock
2026-04-28−2,706→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−11,459→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−8,011→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−9,174→ 0 total
Award
Black Diamond Therapeutics, Inc.$BDTX
Common Stock
2026-03-20$2.15/sh+6,919→ 93,568 total
Award
Korro Bio, Inc.$KRRO
Common Stock
2026-03-10$11.11/sh+207,100→ 1,297,893 total
Award
Korro Bio, Inc.$KRRO
Pre-Funded Warrants
2026-03-10$11.11/sh+242,945→ 242,945 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,619,240→ 1,619,240 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 2,989,408 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 4,359,576 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+737,962→ 5,097,538 total
Purchase
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09$16.00/sh+937,500→ 6,035,038 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+954,990→ 954,990 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+402,273→ 1,357,263 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series B Preferred Stock
2026-02-09−1,619,240→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series C-1 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series C-2 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series D Preferred Stock
2026-02-09−737,962→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series A Preferred Stock
2026-02-09−954,990→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series B Preferred Stock
2026-02-09−402,273→ 0 total
Award
SpyGlass Pharma, Inc.$SGP
Stock Option (right to buy)
2026-02-05+27,400→ 27,400 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+607,536→ 2,261,870 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−182→ 2,384,873 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−2,384,873→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+372,255→ 372,255 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−37,700→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+124,085→ 124,085 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 488,982 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 488,702 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+186,128→ 674,830 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+1,656,789→ 1,656,789 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−1,656,789→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−124,085→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−100,000→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+124,085→ 2,385,055 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−372,255→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+186,128→ 186,128 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−186,128→ 0 total

Recent Filings

Address

2855 SAND HILL ROAD

MENLO PARK, CA, 94025

View on SEC.gov